title: Selectively inhibiting PDE5: a novel therapeutic target for reversing cardiac remodeling in heart failure.
authors.affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Jiefang Road 238, Wuchang, 430060 Wuhan, PR China.
authors.forename: Jichun
authors.initials: J
authors.lastname: Wang
authors.affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Jiefang Road 238, Wuchang, 430060 Wuhan, PR China.
authors.forename: Xiaolin
authors.initials: X
authors.lastname: Wu
authors.affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Jiefang Road 238, Wuchang, 430060 Wuhan, PR China.
authors.forename: Xiaorong
authors.initials: X
authors.lastname: Hu
authors.affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Jiefang Road 238, Wuchang, 430060 Wuhan, PR China. Electronic address: jianghongwhu@163.com.
authors.forename: Hong
authors.initials: H
authors.lastname: Jiang
mesh_terms: D054706:Cyclic Nucleotide Phosphodiesterases, Type 5 / Q000378:metabolism*; D016503:Drug Delivery Systems / Q000379:methods*; D006333:Heart Failure / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D006801:Humans; D058986:Phosphodiesterase 5 Inhibitors / Q000008:administration & dosage*; D020257:Ventricular Remodeling / Q000187:drug effects / Q000502:physiology*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5
keywords: 3′,5′-Cyclicnucleotide phosphodiesterases; Cardiac remodeling; Heart failure